Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Pilot Circuit Breaker Proposal: SEC issues proposal on pilot circuit breaker program to combat abusive short selling

BIO commends the SEC on its pilot circuit breaker proposal and urges the use of biotech companies in such proposal

Sarbanes-Oxley in Financial Services Compromise: Sarbanes-Oxley 404(b) Legislative Text in the Wall Street Reform and Consumer Protection Act of 2009

BIO advocated for a provision in financial services reform that would ease regulatory burdens for small public biotechnology companies.

Letter to the Honorable John Carey

Letter to the Honorable John Carey, Chairman of the Senate Committee on Finance and Financial Institutions in Ohio from BIO, regarding House Bill 66.

Letter to Governor Deval Patrick

BIO letter to Governor Deval Patrick of Massachusetts regarding concerns about Senate Bill 2863.

BIO Testimony regarding Oregan Senate Bill 570

Testimony to the Oregon Senate Environment & Land Use Committee regarding The Oregon Genetically Engineered Pharmaceutical and Industrial Crop Act.

Questions for the District of Columbia Board of Pharmacy for the drafting of SafeRx

Frequently Asked Questions Document

Clinical Trials: ICTRP guidelines

BIO urges the ICTRP to focus on developing a procedure that would address the need to balance the incentive to innovate with the need to provide patients and health care providers with the information they need in order to assess the availability and suitability of a clinical trial.

Clinical Trials: Review of the Declaration of Helsinki

BIO’s comments on the World Medical Association’s (WMA’s) Declaration of Helsinki.

2016 BIO International Convention Super Sessions Announced

The Biotechnology Innovation Organization (BIO) announces the lineup for Super Sessions at the 2016 BIO International Convention, taking place in San Francisco’s Moscone Convention Center from June 6-9. Considered the global event for biotechnology, this year’s program is built around an “Imagine” theme.  Six Super Sessions will run during the course of the four day conference with topics on innovation and a look to the future.

BIO Applauds Advancement of Senate Biomedical Innovation Legislation

BIO President and CEO Jim Greenwood released the following statement regarding today’s Senate HELP Committee mark-up of legislation as part of the Senate biomedical innovation initiative...